Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
06/30/2011 | US20110160163 INHIBITORS OF p38 |
06/30/2011 | US20110160157 Methods of treating an inflammatory-related disease |
06/30/2011 | US20110160136 Polyphenols for the treatment of cartilage disorders |
06/30/2011 | US20110160135 Suppression of neuroendocrine diseases |
06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
06/30/2011 | US20110159120 Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
06/30/2011 | US20110159084 Raloxifene pharmaceutical formulations |
06/30/2011 | US20110159071 Isolation and Identification of Glycosaminoglycans |
06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
06/30/2011 | US20110159068 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support |
06/30/2011 | US20110159057 Hydroxyapatite and bioglass-based pellets, production process and applications of thereof |
06/30/2011 | US20110159053 Preparation of a cell concentrate from a physiological solution |
06/30/2011 | US20110159011 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
06/30/2011 | US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof |
06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
06/30/2011 | US20110158966 Stem cells characterized by expression of germline specific genes |
06/30/2011 | US20110158963 Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof |
06/30/2011 | US20110158960 Isolation of precursor cells and their use for tissue repair |
06/30/2011 | CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
06/30/2011 | CA2785553A1 Treatment of osteoporosis |
06/30/2011 | CA2785116A1 A combination for the treatment of osteoarthritis |
06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
06/30/2011 | CA2687713A1 Treatment of cancer, arthritis, inflammation and other diseases by drawing on skin the big dose of vitamin e in oil and covering by film |
06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
06/29/2011 | EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability |
06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
06/29/2011 | EP2338887A1 Fused heterocyclic derivative and use thereof for medical purposes |
06/29/2011 | EP2338886A2 Naphthalene derivatives |
06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
06/29/2011 | CN201881930U Automobile seat cushion |
06/29/2011 | CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
06/29/2011 | CN102108369A Application of DNA repair protein RAD51 in preparing medicament for treating osteosarcoma |
06/29/2011 | CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
06/29/2011 | CN102106988A Chinese medicine preparation with effects on expelling wind, dispelling cold and dampness, promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain |
06/29/2011 | CN102106975A Traditional Chinese medicine preparation for treating lumbar disease |
06/29/2011 | CN102106966A Preparation method of Chinese medicinal composition with functions of supplementing qi and nourishing blood |
06/29/2011 | CN102106963A Ointment for treating acute gout attack and preparation method thereof |
06/29/2011 | CN102106945A Swelling reliving and tendon and bone-knitting powder |
06/29/2011 | CN102106938A Plant extract for treating gout and kidney disease and preparation method thereof |
06/29/2011 | CN102106923A Chinese medicinal preparation for treating osteoporosis |
06/29/2011 | CN102106921A Fumigating medicament for treating functional obstacle of injured joint |
06/29/2011 | CN102106900A Formula of compound lamiophlomis-root dripping pill |
06/29/2011 | CN102106896A New application of obscured homalomena rhizome (Chinese medicinal plant) in pharmacy |
06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
06/29/2011 | CN102106838A Sulfasalazine enteric-coated preparation and preparation method thereof |
06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
06/29/2011 | CN102106831A 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
06/29/2011 | CN102106801A Natural fatty acid ester peroxide decubitus prevention and treatment product and preparation method thereof |
06/29/2011 | CN101862430B Chinese medicament for treating femoral head necrosis and preparation method thereof |
06/29/2011 | CN101843789B Chinese medicament for treating gout |
06/29/2011 | CN101797320B Medicine composition for preventing hyperosteogeny and preparation process thereof |
06/29/2011 | CN101708265B Rheumatism curing powder |
06/29/2011 | CN101700162B Nano-silver anti-bacterial anion far infrared multifunctional mattress (batts) |
06/29/2011 | CN101647793B Application of anacardic acid in preparing anti-angiogenic drugs |
06/29/2011 | CN101637555B Medicinal liquor soaked with snake |
06/29/2011 | CN101618133B Application of yang-reinforcing kidney-protecting medicine in preparing medicine preventing and treating osteoporosis |
06/29/2011 | CN101554398B Externally applied medical ointment for treating surgical infection and gout and preparation method thereof |
06/29/2011 | CN101507736B Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
06/29/2011 | CN101474268B Application of pharmaceutical composition in preparing medicament for treating bone fracture |
06/29/2011 | CN101406590B Chinese medicinal composition for treating rheumatism osteonosus and preparation method |
06/29/2011 | CN101406581B Ostalgia plaster |
06/29/2011 | CN101390981B Bone fracture traditional Chinese medicine |
06/29/2011 | CN101040949B Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application |
06/29/2011 | CN101001834B Nonpeptide inhibitors of matrix metalloproteinases |
06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
06/28/2011 | US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
06/28/2011 | CA2494700C Calcium receptor modulating compound and use thereof |
06/28/2011 | CA2494613C Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
06/28/2011 | CA2460026C Porous ceramic composite bone grafts |
06/23/2011 | WO2011075643A1 Substituted heteroaryl fused derivatives as pi3k inhibitors |
06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
06/23/2011 | WO2011074758A1 Process for preparing triglyceride oil containing high concentration of polyunsaturated fatty acids |
06/23/2011 | WO2011073546A1 Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium |
06/23/2011 | WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS |